Effects of central apneas on sympathovagal balance and hemodynamics at night: impact of underlying systolic heart failure

Background Increased sympathetic drive is the key determinant of systolic heart failure progression, being associated with worse functional status, arrhythmias, and increased mortality. Central sleep apnea is highly prevalent in systolic heart failure, and its effects on sympathovagal balance (SVB) and hemodynamics might depend on relative phase duration and background pathophysiology. Objective This study compared the effects of central apneas in patients with and without systolic heart failure on SVB and hemodynamics during sleep. Methods During polysomnography, measures of SVB (heart rate and diastolic blood pressure variability) were non-invasively recorded and analyzed along with baroreceptor reflex sensitivity and hemodynamic parameters (stroke volume index, cardiac index, total peripheral resistance index). Data analysis focused on stable non-rapid eye movement N2 sleep, comparing normal breathing with central sleep apnea in subjects with and without systolic heart failure. Results Ten patients were enrolled per group. In heart failure patients, central apneas had neutral effects on SVB (allp > 0.05 for the high, low, and very low frequency components of heart rate and diastolic blood pressure variability). Patients without heart failure showed an increase in very low and low frequency components of diastolic blood pressure variability in response to central apneas (63 +/- 18 vs. 39 +/- 9%;p = 0.001, 43 +/- 12 vs. 31 +/- 15%;p = 0.002). In all patients, central apneas had neutral hemodynamic effects when analyzed over a period of 10 min, but had significant acute hemodynamic effects. Conclusion Effects of central apneas on SVB during sleep depend on underlying systolic heart failure, with neutral effects in heart failure and increased sympathetic drive in idiopathic central apneas.

Automated summary

Central apneas have different effects on sympathovagal balance during sleep depending on underlying systolic heart failure, with neutral effects in heart failure patients and increased sympathetic drive in those with idiopathic central apneas.